The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding unlicensed FSC Black Cohosh 1000mg capsules, highlighting to consumers the importance of using a registered product.  The MHRA has asked the manufacturer to remove the product from the market because it does not have the appropriate authorisation as a medicine and contains 50 times the approved dose for menopausal complaints. The product also had insufficient labelling detailing safety information and side-effects.  It has been found online and is thought to be sold in independent health food shops.

The MHRA notes that there are black cohosh products with a traditional herbal registration (THR) available for the relief of menopausal symptoms which come with a patient information leaflet providing information about the correct use of the product as well as information on any potential side effects.  Please see the link below for further information.